Inhibition of the NF-ΚB pathway as a potential therapeutic target for pediatric supratentorial ependymomas of the ZFTA subgroup (2024)
- Authors:
- USP affiliated authors: QUEIROZ, ROSANE GOMES DE PAULA - FMRP ; VALERA, ELVIS TERCI - FMRP ; SCRIDELI, CARLOS ALBERTO - FMRP ; PEREIRA, EDUARDO AFONSO DA SILVA - FMRP ; XAVIER, ALCIDES EUZEBIO TAVARES - FMRP ; BAPTISTELLA, MARIANE MINUSSI - FMRP ; CANDIDO, MARINA FERREIRA - FMRP ; SILVA, JONAS JOSÉ DA - FMRP ; SILVA, KETERYNE RODRIGUES DA - FCFRP ; SOUSA, GRAZIELLA RIBEIRO DE - FCFRP
- Unidades: FMRP; FCFRP
- Subjects: NEOPLASIAS CEREBRAIS; CRIANÇAS; LINHAGEM CELULAR; PLANTAS MEDICINAIS; FÁRMACOS IMUNOSSUPRESSORES
- Keywords: Supratentorial ependymoma; Pediatric cancer; NF-kB; Triptolide
- Agências de fomento:
- Language: Português
- Imprenta:
- Publisher: Sociedade Brasileira de Genética (SBG)
- Publisher place: Ribeirão Preto
- Date published: 2024
- Source:
- Título: Resumos (e-Book )
- Conference titles: International Congress of the Brazilian Genetics Society
-
ABNT
PEREIRA, Eduardo Afonso da Silva et al. Inhibition of the NF-ΚB pathway as a potential therapeutic target for pediatric supratentorial ependymomas of the ZFTA subgroup. 2024, Anais.. Ribeirão Preto: Sociedade Brasileira de Genética (SBG), 2024. Disponível em: https://www.sbg.org.br/admin/files/book/book_bcovOe2cEJzf.pdf. Acesso em: 10 fev. 2026. -
APA
Pereira, E. A. da S., Xavier, A. E. T., Baptistella, M. M., Candido, M. F., Silva, J. J. da, Silva, K. R. da, et al. (2024). Inhibition of the NF-ΚB pathway as a potential therapeutic target for pediatric supratentorial ependymomas of the ZFTA subgroup. In Resumos (e-Book ). Ribeirão Preto: Sociedade Brasileira de Genética (SBG). Recuperado de https://www.sbg.org.br/admin/files/book/book_bcovOe2cEJzf.pdf -
NLM
Pereira EA da S, Xavier AET, Baptistella MM, Candido MF, Silva JJ da, Silva KR da, Queiroz RG de P, Valera ET, Sousa GR de, Scrideli CA. Inhibition of the NF-ΚB pathway as a potential therapeutic target for pediatric supratentorial ependymomas of the ZFTA subgroup [Internet]. Resumos (e-Book ). 2024 ;[citado 2026 fev. 10 ] Available from: https://www.sbg.org.br/admin/files/book/book_bcovOe2cEJzf.pdf -
Vancouver
Pereira EA da S, Xavier AET, Baptistella MM, Candido MF, Silva JJ da, Silva KR da, Queiroz RG de P, Valera ET, Sousa GR de, Scrideli CA. Inhibition of the NF-ΚB pathway as a potential therapeutic target for pediatric supratentorial ependymomas of the ZFTA subgroup [Internet]. Resumos (e-Book ). 2024 ;[citado 2026 fev. 10 ] Available from: https://www.sbg.org.br/admin/files/book/book_bcovOe2cEJzf.pdf - Exploring blood-brain barrier-crossing drugs for the identification of novel therapies in pediatric medulloblastoma
- Identification of FDA: approved and blood-brain barrierpenetrating drugs for novel therapies in glioblastoma
- Triptolide as a potential chemotherapy for pediatric adrenocortical tumors
- VRK serine/threonine kinase 1 knockdown suppress group 3 medulloblatoma malignant phenotypes
- The TK1 gene as a potential prognostic marker and its correlation with immune cell infiltrates in adrenocortical carcinoma: in silico analyses
- USP2 expression in groups 3 and 4 medulloblastoma: prognostic and therapeutic perspectives
- Estudo de rearranjos gênicos na leucemia linfóide aguda do adulto
- Notch pathway in ependymoma RELA-fused subgroup: upregulation and association with cancer stem cells markers expression
- Caracterização molecular e funcional do gene USP2 em meduloblastoma pediátrico de grupo 3 e 4
- Identification of ITPR1 as a Hub Gene of Group 3 Medulloblastoma and Coregulated Genes with Potential Prognostic Values
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
